Curi RMB Capital’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,640
| Closed | -$403K | – | 502 |
|
|
2022
Q3 | $403K | Hold |
1,640
| – | – | 0.02% | 378 |
|
|
2022
Q2 | $406K | Sell |
1,640
-3
| -0.2% | -$810 | 0.01% | 377 |
|
|
2022
Q1 | $544K | Sell |
1,643
-72
| -4% | -$22.2K | 0.02% | 323 |
|
|
2021
Q4 | $616K | Hold |
1,715
| – | – | 0.02% | 337 |
|
|
2021
Q3 | $558K | Hold |
1,715
| – | – | 0.02% | 336 |
|
|
2021
Q2 | $535K | Hold |
1,715
| – | – | 0.02% | 350 |
|
|
2021
Q1 | $547K | Hold |
1,715
| – | – | 0.02% | 344 |
|
|
2020
Q4 | $556K | Hold |
1,715
| – | – | 0.02% | 413 |
|
|
2020
Q3 | $475K | Sell |
1,715
-150
| -8% | -$43.2K | 0.02% | 427 |
|
|
2020
Q2 | $451K | Sell |
1,865
-665
| -26% | -$134K | 0.02% | 419 |
|
|
2020
Q1 | $367K | Sell |
2,530
-850
| -25% | -$141K | 0.02% | 453 |
|
|
2019
Q4 | $577K | Sell |
3,380
-8,347
| -71% | -$1.55M | 0.02% | 429 |
|
|
2019
Q3 | $2.09M | Sell |
11,727
-430
| -4% | -$92.9K | 0.05% | 291 |
|
|
2019
Q2 | $3.17M | Sell |
12,157
-625
| -5% | -$166K | 0.08% | 245 |
|
|
2019
Q1 | $3.65M | Sell |
12,782
-279
| -2% | -$92.7K | 0.09% | 235 |
|
|
2018
Q4 | $4.25M | Buy |
13,061
+203
| +2% | +$70.5K | 0.11% | 209 |
|
|
2018
Q3 | $5.78M | Sell |
12,858
-8,287
| -39% | -$3.27M | 0.14% | 184 |
|
|
2018
Q2 | $8.65M | Sell |
21,145
-10,324
| -33% | -$3.74M | 0.21% | 136 |
|
|
2018
Q1 | $9.16M | Sell |
31,469
-5,869
| -16% | -$1.49M | 0.23% | 127 |
|
|
2017
Q4 | $7M | Sell |
37,338
-8,631
| -19% | -$1.61M | 0.18% | 165 |
|
|
2017
Q3 | $7.75M | Sell |
45,969
-3,965
| -8% | -$600K | 0.2% | 158 |
|
|
2017
Q2 | $7.16M | Buy |
49,934
+40,194
| +413% | +$5.4M | 0.2% | 157 |
|
|
2017
Q1 | $1.22M | Buy |
9,740
+490
| +5% | +$56.8K | 0.05% | 283 |
|
|
2016
Q4 | $1.04M | Sell |
9,250
-990
| -10% | -$115K | 0.06% | 246 |
|
|
2016
Q3 | $1.32M | Buy |
10,240
+40
| +0.4% | +$4.79K | 0.07% | 220 |
|
|
2016
Q2 | $1.11M | Buy |
10,200
+50
| +0.5% | +$4.97K | 0.06% | 228 |
|
|
2016
Q1 | $962K | Buy |
+10,150
| New | +$857K | 0.06% | 227 |
|
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Curi RMB Capital's ABMD Position: Q4 2022 in Review
Curi RMB Capital sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,640 shares — an estimated $403K sold.
Curi RMB Capital first reported a position in ABMD in Q1 2016 and held it in 27 quarters. The position peaked at $9.16M in Q1 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Curi RMB Capital reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Curi RMB Capital sold 1,640 Abiomed Inc shares in Q4 2022, an estimated $403K.
- Curi RMB Capital first reported a position in Abiomed Inc in Q1 2016 and held it in 27 quarters.
- Curi RMB Capital's Abiomed Inc position peaked at $9.16M in Q1 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Curi RMB Capital's 13F filing for Q4 2022, filed 14 Feb 2023.